Costello J, Erkanli A, Angold A. Is there an epidemic of child or adolescent depression? J Child Psychol Psychiatry. 2006;47:1263–71.
Google Scholar
Coghill D, Bonnar S, Duke S, Graham J, Seth S. Child and adolescent psychiatry. Oxford: Oxford University Press; 2009. ISBN: 978-0-19-923499-8.
Vaváková M, Ďuračková Z, Trebatická J. Markers of oxidative stress and neuroprogression in depression disorder. Oxid Med Cell Longev. 2015;2015:898393. doi:10.1155/2015/898393.
Article
PubMed
PubMed Central
Google Scholar
Colin A, Reggers J, Castronovo V, Ansseau M. Lipds, depression and suicide. Encephale. 2003;29:49–58.
CAS
PubMed
Google Scholar
Sinopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002;56:365–79.
Article
Google Scholar
Caballero-Martínez F, León-Vázquez F, Payá-Pardo A, Díaz-Holgado A. Use of health care resources and loss of productivity in patients with depressive disorders seen in Primary Care: INTERDEP Study. Actas Esp Psiquiatr. 2014;42:281–91.
PubMed
Google Scholar
Lopresti AL, Hood SD, Drummond PD. A review of lifestyle factors that contribute to important pathways associated with major depression: diet, sleep and exercise. J Affect Disord. 2013;148:12–27.
Article
PubMed
Google Scholar
Trebatická J, Dukát A, Ďuračková Z, Muchová J. Cardiovascular diseases, depression disorders and potential effects of omega-3 fatty acids. Physiol Res. 2017;66.
Sarris J, Kavanagh DJ, Byrne G. Adjuvant use of nutritional and herbal medicines with antidepressants, mood stabilizers and benzodiazepines. J Psychiatr Res. 2010;44:32–41.
Article
PubMed
Google Scholar
Clark MS, Jansern KL, Cloy A. Treatment of childhood and adolescent depression. Am Fam Phys. 2012;86:442–8.
Google Scholar
Trebatická J, Ďuračková Z. Psychiatric disorders and polyphenols: can they be helpful in therapy? Oxid Med Cell Longev. 2015;2015:248529. doi:10.1155/2015/248529.
Article
PubMed
PubMed Central
Google Scholar
Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M, et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry. 2006;67:1954–67.
Article
CAS
PubMed
Google Scholar
Lin PY, Su KP. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry. 2007;68:1056–61.
Article
CAS
PubMed
Google Scholar
Martins JG. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acids supplementation in depression: evidence from a meta-analysis of randomized controlled trials. J Am Coll Nutr. 2009;28:525–42.
Article
CAS
PubMed
Google Scholar
Kraguljac NV, Montori VM, Pavuluri M, Chai HS, Wilson BS, Unal SS. Efficacy of omega-3 fatty acids in mood disorders—a systematic review and meta analysis. Psychopharmacol Bull. 2009;42:39–54.
PubMed
Google Scholar
Mello AH, Gassenferth A, Souza LR, Fortunato JJ, Rezin GT. ω-3 and major depression: a review. Acta Neuropsychiatr. 2014;26:178–85.
Article
PubMed
Google Scholar
Bloch MH, Hannestad J. Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis. Mol Psychiatry. 2012;17:1272–82.
Article
CAS
PubMed
Google Scholar
Lin PY, Mischoulon D, Freeman M, Matsuoka Y, Hibbeln J, Belmaker RH, et al. Are omega-3 fatty acids anti-depressants or just mood-improving agents? Mol Psychiatry. 2012;17:1161–3. doi:10.1038/mp.2012.111.
Article
CAS
PubMed
PubMed Central
Google Scholar
Grosso G, Pajak A, Marventano S, Castellano S, Galvano F, Bucolo C, et al. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PLoS ONE. 2014;9:e96905.
Article
PubMed
PubMed Central
Google Scholar
Hallahan B, Ryan T, Hibbeln JR, Murray IT, Glynn S, Ramsden CE, et al. Efficacy of omega-3 highly unsaturated fatty acids in the treatment of depression. Br J Psychiatry. 2016.
Peet M, Horrobin DF, Multicentre Study group E-E. A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoic acid in patients with persistent schizophrenic symptoms. J Psychiatr Res. 2008;36:7–18.
Article
Google Scholar
Freud-Levi Y, Basun H, Cederholm T, Faxen-Irvig G, Garlind A, et al. Omega-3 supplementation in mild to moderate Alzheimer´s disease: effects on neuropsychiatric symptoms. Int J Geriatr Psychiatry. 2008;23:161–9.
Article
Google Scholar
Lin PY, Huang SY, Su KP. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry. 2010;68:140–7.
Article
CAS
PubMed
Google Scholar
Lucas M, Asselin G, Merrete C, Poulin MJ, Dodin S. Ethyl-eicpsapentaenoic acid for the treatment psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled randomized clinical trieal. Am J Clin Nutr. 2009;89:641–51.
Article
CAS
PubMed
Google Scholar
Mischoulon D, Papakostas GI, Dording CM, Farabaugh AH, Sonawalla SB, et al. A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder. J Clin Psychiatry. 2009;70:1636–44.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gertsik L, Poland RE, Bresee C, Rapaport MH. Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder. J Clin Psychopharmacol. 2012;32:61–4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Frangou S, Lewis M, McCrone P. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry. 2006;188:46–50.
Article
PubMed
Google Scholar
Frangou S, Lewis M, Wollard J, Simmons A. Preliminary in vivo evidence increased N-acetyl-aspartate following eicosatentanoic acid treatment in patients with bipolar disorder. J Psychopharmacol. 2007;21:435–9.
Article
CAS
PubMed
Google Scholar
Sublette ME, Ellis SP, Geant AL, Mann JJ. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry. 2011;72:1577–84.
Article
CAS
PubMed
PubMed Central
Google Scholar
Peet M, Horrobin DF. A dose ranging study of the effects of ethyleicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry. 2002;59:913–9.
Article
CAS
PubMed
Google Scholar
Martins JG, Bentsen H, Puri BK. Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis. Mol Psychiatry. 2012. doi:10.1038/mp.2012.25.
Google Scholar
Appleton KM, Sallis HM, Perry R, Ness AR, Churchill R. Omega- fatty acids for depression in adults. Cochrane Database Syst Rev. 2015;11:CD004692. doi:10.1002/14651858.CD004692.pub4.
Google Scholar
Orr SK, Palumbo S, Bosetti F, Mount HT, Kang JX, Greenwood CE, Ma DW, Serhan CN, Bazinet RP. Unesterified docosahexaenoic acid is protective in neuroinflammation. J Neurochem. 2013;127:378–93.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mocking RJT, Harmsen I, Assies J, Kowter MWJ, Ruhé HG, Schene AH. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. Transl Psychiatry. 2016;6:e756.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bylund DB, Reed AL. Childhood and adolescent depression: why do children and adults respond differently to antidepressant drug? Neurochem Int. 2007;51:246–53.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lopresti AL. A review of nutrient treatments for paediatric depression. J Affect Disord. 2015;181:24–32.
Article
CAS
PubMed
Google Scholar
Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry. 2006;163:1098–100.
Article
PubMed
Google Scholar
McNamara RK, Strimpfel J, Jandacek R, Rider T, Tso P, Welge JA, et al. Detection and treatment of long-chain omega-3 fatty acid deficiency in adolescents with SSRI-resistant major depressive disorder. PharmaNutrition. 2014;2:38–46.
Article
CAS
PubMed
PubMed Central
Google Scholar
Clayton EH, Hanstock TL, Hirneth SJ, Kable CJ, Garg ML, Hatell PL. Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation. Eur J Clin Nutr. 2009;63:1037–40.
Article
CAS
PubMed
Google Scholar
Wozniak J, Faraone SV, Chan J, Tarko L, Hermandez M, Davis J, et al. A randomized clinical trial of high eicosapentaenoic acid omega-3 fatty acids and inositol as monotherapy and in combination in the treatment of pediatric bipolar spectrum disorders: a pilot study. J Clin Psychiatry. 2015;76:1548–55.
Article
PubMed
Google Scholar
Amminger GP, Schäfer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry. 2010;67:146–54.
Article
CAS
PubMed
Google Scholar
Murakami K, Miyake Y, Sasaki S, Tanaka K, Arakawa M. Fish and n-3 polyunsaturated fatty acid intake and depressive symptoms: Ryukyus Child Health Study. Pediatrics. 2010;126(3):e623–30. doi:10.1542/peds.2009-3277.
Article
PubMed
Google Scholar
Kovacs M, Feinberg TL, Crouse-Novak MA, Paulauskas SL, Finkelstein R. Depressive disorders in childhood. I. A longitudinal prospective study of characteristics and recovery. Arch Gen Psychiatry. 1984;41:229–37.
Article
CAS
PubMed
Google Scholar
Bang YR, Park JH, Kim SH. Cut-off scores of the children’s depression inventory for screening and rating severity in Korean adolescents. Psychiatry Investig. 2015;12:23–8.
Article
PubMed
PubMed Central
Google Scholar
Kovacs M. CDI childrens depression inventory cdi. 1998, Psychodiagnostika a.s., Bratislava, SR (In Slovak).
Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67:446–57.
Article
CAS
PubMed
Google Scholar
Su KP, Lai HC, Yang HT, Su WP, Peng CY, Chang JP, et al. Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial. Biol Psychiatry. 2014;76:559–66.
Article
CAS
PubMed
Google Scholar
Su KP, Matsuoka Y, Pae CU. Omega-3 polyunsaturated fatty acids in prevention of mood and anxiety disorders. Clin Psychopharmacol Neurosci. 2015;13:129–37.
Article
PubMed
PubMed Central
Google Scholar
Garaiova I, Guschina IA, Plummer SF, Tang J, Wang D, Plummer NT. A randomised cross-over trial in healthy adults indicating improved absorption of omega-3 fatty acids by pre-emulsification. Nutr J. 2007;6:4. doi:10.1186/1475-2891-6-4.
Article
PubMed
PubMed Central
Google Scholar
Raatz SK, Redmon JB, Wimmergren N, Donadio JV, Bibus DM. Enhanced absorption of n-3 fatty acids from emulsified compared with encapsulated fish oil. J Am Diet Assoc. 2009;109:1076–81.
Article
CAS
PubMed
PubMed Central
Google Scholar
Masip AF, Amador-Campos JA, Gómez-Benito J, Gándara VDB. Psychometric properties of the children’s depression inventory in community and clinical sample. Span J Psychol. 2010;13:990–9.
Article
Google Scholar
Nolen-Hoeksema S, Girgus JS. Explanatory style and achievement, depression, and gender differences in childhood and early adolescence. In: Buchanan GM, Seligman MEP, editors. Explanatory style. Hillsdale: Lawrence Erlbaum Associates; 1993. p. 57–70.
Google Scholar
Lespérance F, Frasure-Smith N, St-André E, Turecki G, Lespérance P, Wisniewski SR. The efficacy of omega-3 supplementation for major depression: a randomized controlled trial. J Clin Psychiatry. 2011;72:1054–62.
Article
PubMed
Google Scholar
Liu JJ, Galfavy HC, Cooper TB, Oquendo MA, Grunebaum MF, Mann JJ, et al. omega-3 polyunsaturated fatty acids (PUFA) status in major depressive disorder with comorbid anxiety disoerder. J Clin Psychiatry. 2013;74:732–8.
Article
CAS
PubMed
PubMed Central
Google Scholar